Severe eosinophilic asthma

Severe eosinophilic asthma is a rare type of asthma, that do not respond t the usually asthma drug treatments (corticosteroids). That means that it’s harder to manage, so asthma attacks will possibly occur. This type of asthma involves the abnormal production of type 2 cytokines from T-helper 2 and innate lymphoid cells.

Showing all 3 results

Filter our product list:
API
Antigen / Target
Therapeutic Areas
Therapeutic Indications
Classes of molecule​s
Isotypes
Expiry Date
CoA
Filters Sort results
Reset Apply

Product
Batch

Antigen
Molecular Class
Drug Brand
Product Concentration
CoA
Quantity per vial
Storage Temperature
Expiry Date
Price
IL-5 receptor alpha
Monoclonal Antibody
Fasenra ®
30 mg/mL
1,5 mg
tba
tba
939,00 
view product
Max:
Min: 4
Step: 1
IL-13
,
IL-4
Monoclonal Antibody
Dupixent®
150 mg/mL
12 mg
2-8°C/-80°C
10/2023
451,00 
view product
Max: 10
Min: 0
Step: 1
IL-5
Monoclonal Antibody
Nucala®
100 mg/mL
4 mg
tba
tba
529,00 
view product
Max:
Min: 5
Step: 1

Not looking for Severe eosinophilic asthma?

Search our therapeutic molecules product database

Evidentic Support
+49 (0) 30 959 99 8831

Let us know about your inquiry details and we’ll contact you shortly.

we are recruiting